title: Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity.
abstract: Endocannabinoids (eCBs) are involved in the stress response and alterations in eCB signaling may contribute to the etiology of mood disorders. Exposure to chronic mild stress (CMS), a model of depression, produces downregulation of the cannabinoid 1 (CB1) receptor in the hippocampus of male rats. However, it is unknown how this stress-induced change in CB1 levels affects eCB-mediated neurotransmission. In vitro, field potential recordings from CMS-exposed (21-days) rats were performed to assess the effects of stress on eCB-regulated glutamatergic neurotransmission in/on hippocampal area CA1. We observed that application of the CB1 agonist, WIN 55,212-5 (1 μM), in stress animals resulted in a ∼135% increase in excitatory neurotransmission, whereas CB1 activation in non-stress animals leads to a ∼30% decrease. However, during blockade of GABA(A) neurotransmission with picrotoxin, CB1 activation yielded a ∼35% decrease in stress animals. These findings indicate that CMS does not directly affect glutamatergic neurotransmission. Rather, CMS sensitizes CB1 function on GABAergic terminals, leading to less inhibition and an increase in excitatory neurotransmission. This finding is reinforced in that induction of weak long-term-potentiation (LTP) is enhanced in CMS-exposed animals compared to controls and this enhancement is CB1-dependent. Lastly, we observed that the LTP-blocking property of WIN 55,212-5 shifts from being glutamate-dependent in non-stress animals to being GABA-dependent in stress animals. These results effectively demonstrate that CMS significantly alters hippocampal eCB-mediated neurotransmission and synaptic plasticity.
authors.affiliation: Program in Psychology, Ramapo College of New Jersey, Mahwah, NJ 07430, USA. Electronic address: creich@ramapo.edu.
authors.forename: C G
authors.initials: CG
authors.lastname: Reich
authors.forename: G R
authors.initials: GR
authors.lastname: Mihalik
authors.forename: A N
authors.initials: AN
authors.lastname: Iskander
authors.forename: J C
authors.initials: JC
authors.lastname: Seckler
authors.forename: M S
authors.initials: MS
authors.lastname: Weiss
mesh_terms: D000818:Animals; D048588:Benzoxazines / Q000494:pharmacology; D002908:Chronic Disease; D004195:Disease Models, Animal; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects* / Q000502:physiology; D018756:GABA Antagonists / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000502:physiology*; D006624:Hippocampus / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D009473:Neuronal Plasticity / Q000187:drug effects* / Q000502:physiology; D010852:Picrotoxin / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D013315:Stress, Psychological / Q000473:pathology*; D009435:Synaptic Transmission / Q000187:drug effects
chemical_list: D048588:Benzoxazines; D018756:GABA Antagonists; D009025:Morpholines; D009281:Naphthalenes; D010852:Picrotoxin; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; C103505:AM 251; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
keywords: 2-AG; 2-arachidonoyl-glycerol; ACSF; AEA; ANOVA; CB; CB1 receptor; CCK; CMS; CRS; DMSO; DSI; GC; HPA; LTP; MANOVAs; NS; PND; PTSD; PTX; S; TBS; analysis of variance; artificial cerebrospinal fluid; cannabinoid; cholecystokinin; chronic mild stress; chronic restraint stress; depolarization-induced-suppression of inhibition; depression; dimethyl sulfoxide; eCBs; endocannabinoid/endovanniloid anandamide; endocannabinoids; glucocorticoid; hippocampus; hypothalamic–pituitary–adrenal; long-term-potentiation; multivariate ANOVA; non-stress; picrotoxin; post natal day; post-traumatic-stress-disorder; stress; theta-burst stimulation
references.citation: J Psychopharmacol. 2013 Oct;27(10):947-55
references.pmid: 23926242
references.citation: J Psychopharmacol. 2012 Jan;26(1):56-70
references.pmid: 21890595
references.citation: J Neurosci. 2008 Jul 16;28(29):7284-92
references.pmid: 18632932
references.citation: Physiol Behav. 2007 Jan 30;90(1):29-35
references.pmid: 17023009
references.citation: J Neurochem. 2008 Sep;106(6):2322-36
references.pmid: 18643796
references.citation: J Neurosci. 2006 May 24;26(21):5794-9
references.pmid: 16723537
references.citation: Proc Natl Acad Sci U S A. 2010 May 18;107(20):9406-11
references.pmid: 20439721
references.citation: Neuropsychopharmacology. 2010 Oct;35(11):2249-61
references.pmid: 20664582
references.citation: J Neurosci. 2002 Aug 1;22(15):6810-8
references.pmid: 12151561
references.citation: Nat Neurosci. 2010 May;13(5):592-600
references.pmid: 20348918
references.citation: Eur J Pharmacol. 1994 Jul 11;259(3):R7-8
references.pmid: 7982446
references.citation: Neuron. 2004 Sep 16;43(6):871-81
references.pmid: 15363397
references.citation: Br J Pharmacol. 1995 Jul;115(6):869-70
references.pmid: 7582512
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1575-85
references.pmid: 21111017
references.citation: Horm Behav. 2003 Nov;44(4):338-45
references.pmid: 14613728
references.citation: J Neurosci. 2006 Mar 15;26(11):2991-3001
references.pmid: 16540577
references.citation: Nat Neurosci. 2002 Aug;5(8):723-4
references.pmid: 12080342
references.citation: Behav Neurosci. 1999 Oct;113(5):902-13
references.pmid: 10571474
references.citation: Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
references.pmid: 10817843
references.citation: Eur J Neurosci. 2003 May;17(9):1928-34
references.pmid: 12752792
references.citation: Biol Psychiatry. 2007 Jul 1;62(1):92-100
references.pmid: 17141742
references.citation: Brain Res Bull. 1987 Dec;19(6):663-72
references.pmid: 2830949
references.citation: Neuropsychobiology. 2005;52(2):90-110
references.pmid: 16037678
references.citation: J Physiol (Paris). 1986;81(4):228-36
references.pmid: 2883309
references.citation: Neuropsychopharmacology. 2009 Dec;34(13):2699-709
references.pmid: 19675536
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1995 Nov;352(5):576-9
references.pmid: 8751088
references.citation: Stress. 2009 Jan;12(1):1-21
references.pmid: 19116888
references.citation: Neuroscience. 2012 Mar 1;204:83-9
references.pmid: 21939741
references.citation: Neuropsychopharmacology. 2005 Mar;30(3):508-15
references.pmid: 15525997
references.citation: Eur J Neurosci. 2005 Nov;22(9):2387-91
references.pmid: 16262678
references.citation: Hippocampus. 2002;12(2):245-57
references.pmid: 12000121
references.citation: Psychopharmacology (Berl). 2002 Feb;159(4):379-87
references.pmid: 11823890
references.citation: Physiol Rev. 2009 Jan;89(1):309-80
references.pmid: 19126760
references.citation: J Physiol. 1999 Nov 15;521 Pt 1:147-57
references.pmid: 10562341
references.citation: Trends Neurosci. 2003 Sep;26(9):489-95
references.pmid: 12948660
references.citation: Behav Brain Res. 2006 Nov 11;174(2):215-24
references.pmid: 16876265
references.citation: Hippocampus. 2008;18(2):221-6
references.pmid: 18058925
references.citation: Ann N Y Acad Sci. 2008 Dec;1148:64-73
references.pmid: 19120092
references.citation: Neuropsychopharmacology. 2011 Dec;36(13):2750-61
references.pmid: 21849983
references.citation: Neuroscience. 2012 Mar 1;204:17-30
references.pmid: 22015924
references.citation: Neuroscience. 2006;139(3):795-802
references.pmid: 16527424
references.citation: Behav Brain Res. 2009 Nov 5;203(2):264-9
references.pmid: 19460405
references.citation: Brain Res Bull. 2011 Jul 15;85(6):374-9
references.pmid: 21527320
references.citation: Eur J Neurosci. 2008 Mar;27(6):1503-16
references.pmid: 18336570
references.citation: Depress Anxiety. 2010 Apr;27(4):351-64
references.pmid: 20037917
references.citation: J Neurosci. 2010 Aug 18;30(33):11188-96
references.pmid: 20720126
references.citation: J Neurosci. 1999 Aug 15;19(16):6795-805
references.pmid: 10436037